Axsome Therapeutics (AXSM) PT Raised to $207 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Price: $216.27 +1.22%
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Sean Laaman raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $207.00 (from $204.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Axsome Therapeutics (AXSM) PT Raised to $316 at Mizuho
- Axsome Therapeutics (AXSM) PT Lowered to $279 at RBC Capital
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
